CHOICE KERGUELEN 2 : Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands : Follow-up of Volunteers on the Kerguelen Islands

Recruiting Observational Study
Human Health in Extreme Conditions
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
9 (estimated)
Sponsor
University Hospital, Angers · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Living for long periods in extreme environments-like Antarctic research stations or space missions-can have a significant impact on human health, especially on the immune system. Scientists have observed that people in such isolated conditions often experience more infections and a reactivation of viruses that usually stay dormant in the body, such as Herpes viruses. These changes affect both part…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria : * healthy people aged \> 18 years * Participant affiliated with or benefiting from a social security system * Participant has signed informed consent * Participant staying as an overwintering member at Kerguelen from November 2025 to November 2026 * Participant included in the …
Contacts

Charline MIOT, MD

02 41 35 36 37

chmiot@chu-angers.fr

CONTACT

Anthéa LOIEZ

02 41 35 36 37

DRCI-Promotion-Interne@chu-angers.fr

CONTACT